| Diagnosis and treatment of hyperprolactinemia: an Endocrine Society clinical practice guideline. | |
| | |
MedLine Citation:
|
PMID: 21296991 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
OBJECTIVE: The aim was to formulate practice guidelines for the diagnosis and treatment of hyperprolactinemia. PARTICIPANTS: The Task Force consisted of Endocrine Society-appointed experts, a methodologist, and a medical writer. EVIDENCE: This evidence-based guideline was developed using the Grading of Recommendations, Assessment, Development, and Evaluation (GRADE) system to describe both the strength of recommendations and the quality of evidence. CONSENSUS PROCESS: One group meeting, several conference calls, and e-mail communications enabled consensus. Committees and members of The Endocrine Society, The European Society of Endocrinology, and The Pituitary Society reviewed and commented on preliminary drafts of these guidelines. CONCLUSIONS: Practice guidelines are presented for diagnosis and treatment of patients with elevated prolactin levels. These include evidence-based approaches to assessing the cause of hyperprolactinemia, treating drug-induced hyperprolactinemia, and managing prolactinomas in nonpregnant and pregnant subjects. Indications and side effects of therapeutic agents for treating prolactinomas are also presented. |
| | |
Authors:
|
Shlomo Melmed; Felipe F Casanueva; Andrew R Hoffman; David L Kleinberg; Victor M Montori; Janet A Schlechte; John A H Wass; |
Publication Detail:
|
Type: Guideline; Journal Article; Research Support, Non-U.S. Gov't; Review |
Journal Detail:
|
Title: The Journal of clinical endocrinology and metabolism Volume: 96 ISSN: 1945-7197 ISO Abbreviation: J. Clin. Endocrinol. Metab. Publication Date: 2011 Feb |
Date Detail:
|
Created Date: 2011-02-07 Completed Date: 2011-03-21 Revised Date: 2011-06-06 |
Medline Journal Info:
|
Nlm Unique ID: 0375362 Medline TA: J Clin Endocrinol Metab Country: United States |
Other Details:
|
Languages: eng Pagination: 273-88 Citation Subset: AIM; IM |
Affiliation:
|
Cedars Sinai Medical Center, Los Angeles, California 90048, USA. |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Adult Evidence-Based Medicine Female Humans Hyperprolactinemia / chemically induced, diagnosis*, etiology, pathology Pituitary Neoplasms / complications, drug therapy* Pregnancy Prolactinoma / complications, drug therapy |
| Comments/Corrections | |
Comment In:
|
Nat Rev Endocrinol. 2011 May;7(5):247
[PMID:
21502938
]
|
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Approach to the pregnant patient with thyroid cancer.
Next Document: Efficient generation of transgene-free induced pluripotent stem cells from normal and neoplastic bon...